Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)

NCT03704415 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT03704415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03704415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)
Lead sponsor
Helsinki University Central Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 23, 2018
Completion date
October 23, 2024
Enrollment
97 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin sensitivity, asthma, nasal polyps, sinusitis, chronic